Article
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Acta tropica - 1 Dec 2016
Kateera Fredrick, Nsobya Sam L, Tukwasibwe Steven, Hakizimana Emmanuel, Mutesa Leon, Mens Petra F, Grobusch Martin P, van Vugt Michèle, Kumar Nirbhay
Abstract excerpt
Faced with intense levels of chloroquine (CQ) resistance in Plasmodium falciparum malaria, Rwanda replaced CQ with amodiaquine (AQ)+sulfadoxine-pyrimethamine (SP) in 2001, and subsequently with artemether-lumefantrine (AL) in 2006, as first-line treatments for uncomplicated malaria. Following yea...
Topics
- Adolescent
- Amodiaquine
- Antimalarials
- Child
- Child, Preschool
- Chloroquine
- Drug Combinations
- Drug Resistance
- Female
- Genotype
- Haplotypes
